Overview
Location
New Zealand, Auckland
Employees
11-50
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 29, 2017 | Fintech in New Zealand Grows Despite Lack of Clear Strategy from Government | Despite the several initiatives introduced to encourage fintech development, New Zealand is still falling behind other countries such as the UK, the US and China in the support it provides to boost the sector, according to industry observer... |
| Aug 7, 2014 | St. Jude closes $200M NeuroTherm buy | Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm. The deal makes St. Jude the only company in the space with both radiofre... |
| Jun 2, 2014 | St. Jude Medical closes $455M CardioMEMS buy | St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S. &q... |
| Jan 24, 2012 | St. Jude lands $27 million in patent win against Access Closure | Updated 1/23/2012 at 12:00 p.m. with comment from St. Jude Medical. St. Jude Medical (NYSE:STJ) won $27.1 million in a patent infringement decision against Access Closure Inc. over technologies used to close holes in arteries. Judge Harry B... |
Reviews 0
FAQ about Jude
What has the press written about Jude?
Parsers VC has collected 5 articles mentioning Jude, among them “Fintech in New Zealand Grows Despite Lack of Clear Strategy from Government” (Aug 29, 2017) and “St. Jude closes $200M NeuroTherm buy” (Aug 7, 2014).
Is Jude still active?
Yes, Jude is active; its latest activity on Parsers VC dates from Aug 12, 2019.